Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 4/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.58 |
| ▸ | ABAT | P80404 | 1/20 | 0.58 |
| ▸ | DRD1 | P21728 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | KIF11 | P52732 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.50 |
| ▸ | ALDH1A3 | P47895 | 2/20 | 0.46 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.46 |
| ▸ | BRD4 | O60885 | 1/20 | 0.45 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.44 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25288128 | 1.00 | CYP2A6 (0.58) | CYP2A6HSD17B10ALDH5A1ABATDRD1 | |
| SCHEMBL1666706 | 1.00 | CYP2A6 (0.58) | CYP2A6HSD17B10ALDH5A1ABATDRD1 | |
| Hydrochloric Acid SCHEMBL7799271 | 0.97 | CYP2A6 (0.55) | CYP2A6HSD17B10ALDH5A1ABATDRD1 | |
| Hydrogen Sulfide SCHEMBL21407995 | 0.97 | CYP2A6 (0.55) | CYP2A6HSD17B10ALDH5A1ABATDRD1 | |
| Hydrochloric Acid SCHEMBL11476850 | 0.97 | CYP2A6 (0.55) | CYP2A6HSD17B10ALDH5A1ABATDRD1 | |
| SCHEMBL4096252 | 0.91 | CYP2A6 (0.50) | CYP2A6HSD17B10ALDH5A1ABATDRD1 | |
| SCHEMBL5711166 | 0.91 | CYP2A6 (0.55) | CYP2A6HSD17B10ALDH5A1ABATDRD1 | |
| SCHEMBL25249571 | 0.91 | CYP2A6 (0.50) | CYP2A6HSD17B10ALDH5A1ABATDRD1 | |
| SCHEMBL31171 | 0.89 | CYP2A6 (0.69) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 | |
| SCHEMBL4956384 | 0.89 | CYP2A6 (0.69) | CYP2A6HSD17B10ALDH5A1ABATALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 811 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121471465-B | Conjugated microporous polymer based on 4,4' -biphenyl dicarboxaldehyde, preparation method and application | 吉林医药学院 | 2026-05-22 | — | — | CN | claimed |
| CN-122057387-A | Novel ion exchange membrane with high selectivity and permeability and preparation method and application thereof | 浙江大学 | 2026-05-19 | — | — | CN | claimed |
| EP-4686720-A1 | SYNTHESIS OF ORGANIC MACROCYCLES THROUGH CLIP-OFF CHEMISTRY | Fundació Institut Català de Nanociència i Nanotecnologia (ICN2) (ES) | 2026-02-04 | — | — | EP | claimed |
| US-20260021480-A1 | PRODUCTION METHOD OF POROUS MATERIALS | UNIV NAT TAIWAN SCIENCE & TECHNOLOGY (TW) | 2026-01-22 | — | — | US | claimed |
| US-12427506-B1 | Method for carbon dioxide fixation using a palladium-doped nitrogen-rich organic framework catalyst | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-09-30 | — | — | US | claimed |
| CN-119928351-B | Nanofiber composite filter material and preparation process | 博裕纤维科技（苏州）有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-120079430-A | Chemical bonding type heterostructure photocatalyst based on pyrenyl covalent organic framework, preparation method and application | 宁波诺丁汉大学 | 2025-06-03 | — | — | CN | claimed |
| CN-120054227-A | Deep purification PM and SO2Covalent organic framework in-situ crosslinking crystalline state supermembrane and preparation method thereof | 中国矿业大学 | 2025-05-30 | — | — | CN | claimed |
| CN-120073222-A | Preparation method of amphoteric ion covalent organic framework modified diaphragm for lithium-sulfur battery, modified diaphragm and lithium-sulfur battery | 吉林师范大学 | 2025-05-30 | — | — | CN | claimed |
| CN-120040458-A | I-type organic molecular cage porous liquid and preparation method thereof | 北京理工大学 | 2025-05-27 | — | — | CN | claimed |
| EP-1112174-A4 | ISOSORBIDE CONTAINING POLYESTERS AND METHODS FOR MAKING SAME | DU PONT (US) | 2002-05-22 | — | — | EP | claimed |
| EP-1112174-A1 | ISOSORBIDE CONTAINING POLYESTERS AND METHODS FOR MAKING SAME | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2001-07-04 | — | — | EP | claimed |
| US-6063464-A | HEATING WITH CATALYST; ISOSORBIDE IS A RENEWABLE MONOMER | HNA HOLDINGS, INC. (US) | 2000-05-16 | — | — | US | claimed |
| WO-1999054119-A1 | ISOSORBIDE CONTAINING POLYESTERS AND METHODS FOR MAKING SAME | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-10-28 | — | — | WO | claimed |
| US-4841009-A | Substantially linear monomeric composition and liquid crystal polymeric compositions derived therefrom | AMOCO CORPORATION (US) | 1989-06-20 | — | — | US | claimed |
| EP-0054511-B1 | 4-STYRYL-4'-VINYLBIFENYLS, METHODS FOR THEIR PREPARATION AND THEIR USE AS OPTICAL WHITENERS | CIBA-GEIGY AG (CH) | 1987-05-13 | — | — | EP | claimed |
| US-4508784-A | 4-Styryl-4'-vinylbiphenyls, the production thereof and use thereof as fluorescent | CIBA GEIGY CORPORATION (US) | 1985-04-02 | — | — | US | claimed |
| EP-0054511-A2 | 4-Styryl-4'-vinylbifenyls, methods for their preparation and their use as optical whiteners | CIBA-GEIGY AG (CH) | 1982-06-23 | — | — | EP | claimed |
| US-3970579-A | Low melting liquid-crystal mixtures | OWENS-ILLINOIS, INC. (US) | 1976-07-20 | — | — | US | claimed |
| US-3951993-A | HYPOTENSIVE, CORONARY VESSEL DILATORS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-04-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12427506-B1 | Method for carbon dioxide fixation using a palladium-doped nitrogen-rich organic framework catalyst | POF1B, CYP4F12, ETFB | CYP2A6 1032/4885HSD17B10 1428/4885ALDH5A1 581/4885 |
| US-20260021480-A1 | PRODUCTION METHOD OF POROUS MATERIALS | F2, F5, C9 | CYP2A6 1178/4885HSD17B10 2502/4885ALDH5A1 375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.